AstraZeneca PLC (AZN) Earnings Yield: 3.64%
Is AstraZeneca PLC’s earnings yield high or low?
AstraZeneca PLC's earnings yield of 3.64% is 44% above its 5-year average of 2.53%, near the high end of its 5-year range (0.21%–3.87%).
As of Friday, June 12, 2026. 7.97% above its 12-month average of 3.37%.
AZN Earnings Yield Chart
AZN Average Earnings Yield Chart
AZN Current vs Average Earnings Yield Chart
AZN Earnings Yield Metrics
EARNINGS YIELD
3.64%
EARNINGS YIELD AVG TTM
3.37%
EARNINGS YIELD AVG 3Y
3.08%
EARNINGS YIELD AVG 5Y
2.53%
EARNINGS YIELD AVG 10Y
2.66%
EARNINGS YIELD AVG 15Y
4.17%
EARNINGS YIELD AVG 20Y
5.59%
CURRENT VS TTM AVG
+7.97%
CURRENT VS 3Y AVG
+18.12%
CURRENT VS 5Y AVG
+43.84%
CURRENT VS 10Y AVG
+37.07%
CURRENT VS 15Y AVG
-12.81%
CURRENT VS 20Y AVG
-34.87%
AZN Competitors' Earnings Yield
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| AstraZeneca PLC (AZN) | $282.69B | 3.64% | 3.37% | 3.08% | 2.53% |
| Merck & Co., Inc. (MRK) | $298.29B | 2.94% | 6.88% | 4.56% | 4.76% |
| UnitedHealth Group Incorporated (UNH) | $368.30B | 3.26% | 6.03% | 4.62% | 4.30% |
| Amgen Inc. (AMGN) | $191.09B | 4.06% | 4.01% | 3.83% | 4.18% |
| Thermo Fisher Scientific Inc. (TMO) | $176.77B | 3.82% | 3.47% | 3.14% | 3.26% |
| AbbVie Inc. (ABBV) | $397.12B | 0.91% | 0.93% | 1.66% | 2.60% |
| Gilead Sciences, Inc. (GILD) | $156.28B | 5.83% | 4.74% | 3.69% | 4.38% |
| Abbott Laboratories (ABT) | $156.15B | 4.00% | 5.49% | 4.05% | 3.87% |
| Pfizer Inc. (PFE) | $149.18B | 5.01% | 6.28% | 6.38% | 7.46% |
| Intuitive Surgical, Inc. (ISRG) | $146.23B | 2.00% | 1.54% | 1.36% | 1.43% |
Earnings Yield vs P/E Ratio
Earnings Yield
3.64%
EPS ÷ Price
P/E Ratio
27.4
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
- It expresses earnings relative to share price as a percentage
- It can be compared with FCF yield and dividend yield
- It can be compared with bond yields because both are percentages
- It is mathematically the inverse of the P/E ratio
AstraZeneca PLC Earnings Yield Formula & Definition
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
AstraZeneca PLC Earnings Yield FAQ
- What is the earnings yield for AstraZeneca PLC (AZN)?
- The earnings yield for AZN stock is 3.64%.
- Is AstraZeneca PLC's earnings yield high or low?
- AstraZeneca PLC's earnings yield of 3.64% is 44% above its 5-year average of 2.53%, near the high end of its 5-year range (0.21%–3.87%).
- What is the TTM average earnings yield for AstraZeneca PLC (AZN)?
- The TTM average earnings yield for AZN stock is 3.37%.
- What is the 3Y average earnings yield for AstraZeneca PLC (AZN)?
- The 3Y average earnings yield for AZN stock is 3.08%.
- What is the 5Y average earnings yield for AstraZeneca PLC (AZN)?
- The 5Y average earnings yield for AZN stock is 2.53%.
- What is the 10Y average earnings yield for AstraZeneca PLC (AZN)?
- The 10Y average earnings yield for AZN stock is 2.66%.
- What is the 15Y average earnings yield for AstraZeneca PLC (AZN)?
- The 15Y average earnings yield for AZN stock is 4.17%.
- What is the 20Y average earnings yield for AstraZeneca PLC (AZN)?
- The 20Y average earnings yield for AZN stock is 5.59%.
AstraZeneca PLC Earnings Yield History
| DATE | EARNINGS YIELD |
|---|---|
| 2026-06-11 | 3.64% |
| 2026-06-10 | 3.71% |
| 2026-06-09 | 3.62% |
| 2026-06-08 | 3.66% |
| 2026-06-05 | 3.57% |
| 2026-06-04 | 3.65% |
| 2026-06-03 | 3.77% |
| 2026-06-02 | 3.74% |
| 2026-06-01 | 3.70% |
| 2026-05-29 | 3.58% |
| 2026-05-28 | 3.58% |
| 2026-05-27 | 3.58% |
| 2026-05-26 | 3.55% |
| 2026-05-22 | 3.55% |
| 2026-05-21 | 3.50% |
| 2026-05-20 | 3.54% |
| 2026-05-19 | 3.60% |
| 2026-05-18 | 3.61% |
| 2026-05-15 | 3.66% |
| 2026-05-14 | 3.59% |
| 2026-05-13 | 3.54% |
| 2026-05-12 | 3.60% |
| 2026-05-11 | 3.65% |
| 2026-05-08 | 3.63% |
| 2026-05-07 | 3.64% |
| 2026-05-06 | 3.59% |
| 2026-05-05 | 3.66% |
| 2026-05-04 | 3.62% |
| 2026-05-01 | 3.59% |
| 2026-04-30 | 3.54% |
| 2026-04-29 | 3.59% |
| 2026-04-28 | 3.50% |
| 2026-04-27 | 3.49% |
| 2026-04-24 | 3.45% |
| 2026-04-23 | 3.40% |
| 2026-04-22 | 3.36% |
| 2026-04-21 | 3.34% |
| 2026-04-20 | 3.26% |
| 2026-04-17 | 3.19% |
| 2026-04-16 | 3.26% |
| 2026-04-15 | 3.25% |
| 2026-04-14 | 3.20% |
| 2026-04-13 | 3.23% |
| 2026-04-10 | 3.21% |
| 2026-04-09 | 3.19% |
| 2026-04-08 | 3.20% |
| 2026-04-07 | 3.26% |
| 2026-04-06 | 3.22% |
| 2026-04-02 | 3.21% |
| 2026-04-01 | 3.26% |
| 2026-03-31 | 3.32% |
| 2026-03-30 | 3.37% |
| 2026-03-27 | 3.47% |
| 2026-03-26 | 3.57% |
| 2026-03-25 | 3.50% |
| 2026-03-24 | 3.52% |
| 2026-03-23 | 3.55% |
| 2026-03-20 | 3.56% |
| 2026-03-19 | 3.46% |
| 2026-03-18 | 3.47% |
| 2026-03-17 | 3.42% |
| 2026-03-16 | 3.41% |
| 2026-03-13 | 3.44% |
| 2026-03-12 | 3.40% |
| 2026-03-11 | 3.38% |
| 2026-03-10 | 3.35% |
| 2026-03-09 | 3.35% |
| 2026-03-06 | 3.37% |
| 2026-03-05 | 3.31% |
| 2026-03-04 | 3.25% |
| 2026-03-03 | 3.24% |
| 2026-03-02 | 3.21% |
| 2026-02-27 | 3.14% |
| 2026-02-26 | 3.21% |
| 2026-02-25 | 3.18% |
| 2026-02-24 | 3.17% |
| 2026-02-23 | 2.94% |
| 2026-02-20 | 2.95% |
| 2026-02-19 | 2.89% |
| 2026-02-18 | 2.89% |
| 2026-02-17 | 2.87% |
| 2026-02-13 | 2.93% |
| 2026-02-12 | 2.94% |
| 2026-02-11 | 2.94% |
| 2026-02-10 | 3.12% |
| 2026-02-09 | 3.20% |
| 2026-02-06 | 3.12% |
| 2026-02-05 | 3.22% |
| 2026-02-04 | 3.21% |
| 2026-02-03 | 3.27% |
| 2026-02-02 | 3.19% |
| 2026-01-30 | 3.22% |
| 2026-01-29 | 3.29% |
| 2026-01-28 | 3.21% |
| 2026-01-27 | 3.20% |
| 2026-01-26 | 3.36% |
| 2026-01-23 | 3.39% |
| 2026-01-22 | 3.35% |
| 2026-01-21 | 3.44% |
| 2026-01-20 | 3.29% |
| 2026-01-16 | 3.15% |
| 2026-01-15 | 3.19% |
| 2026-01-14 | 3.16% |
| 2026-01-13 | 3.19% |
| 2026-01-12 | 3.25% |
| 2026-01-09 | 3.15% |
| 2026-01-08 | 3.19% |
| 2026-01-07 | 3.16% |
| 2026-01-06 | 3.16% |
| 2026-01-05 | 3.36% |
| 2026-01-02 | 3.29% |
| 2025-12-31 | 3.43% |
| 2025-12-30 | 3.33% |
| 2025-12-29 | 3.22% |
| 2025-12-26 | 3.32% |
| 2025-12-24 | 3.23% |
| 2025-12-23 | 3.29% |
| 2025-12-22 | 3.33% |
| 2025-12-19 | 3.32% |
| 2025-12-18 | 3.33% |
| 2025-12-17 | 3.26% |
| 2025-12-16 | 3.29% |
| 2025-12-15 | 3.27% |
| 2025-12-12 | 3.35% |
| 2025-12-11 | 3.33% |
| 2025-12-10 | 3.31% |
| 2025-12-09 | 3.36% |
| 2025-12-08 | 3.33% |
| 2025-12-05 | 3.35% |
| 2025-12-04 | 3.34% |
| 2025-12-03 | 3.28% |
| 2025-12-02 | 3.36% |
| 2025-12-01 | 3.34% |
| 2025-11-28 | 3.28% |
| 2025-11-26 | 3.19% |
| 2025-11-25 | 3.21% |
| 2025-11-24 | 3.29% |
| 2025-11-21 | 3.30% |
| 2025-11-20 | 3.39% |
| 2025-11-19 | 3.35% |
| 2025-11-18 | 3.44% |
| 2025-11-17 | 3.44% |
| 2025-11-14 | 3.44% |
| 2025-11-13 | 3.39% |
| 2025-11-12 | 3.43% |
| 2025-11-11 | 3.44% |
| 2025-11-10 | 3.44% |
| 2025-11-07 | 3.62% |
| 2025-11-06 | 3.56% |
| 2025-11-05 | 3.28% |
| 2025-11-04 | 3.22% |
| 2025-11-03 | 3.29% |
| 2025-10-31 | 3.23% |
| 2025-10-30 | 3.23% |
| 2025-10-29 | 3.25% |
| 2025-10-28 | 3.21% |
| 2025-10-27 | 3.24% |
| 2025-10-24 | 3.25% |
| 2025-10-23 | 3.16% |
| 2025-10-22 | 3.19% |
| 2025-10-21 | 3.16% |
| 2025-10-20 | 3.19% |
| 2025-10-17 | 3.11% |
| 2025-10-16 | 3.15% |
| 2025-10-15 | 3.17% |
| 2025-10-14 | 3.15% |
| 2025-10-13 | 3.15% |
| 2025-10-10 | 3.14% |
| 2025-10-09 | 3.13% |
| 2025-10-08 | 3.09% |
| 2025-10-07 | 3.13% |
| 2025-10-06 | 3.09% |
| 2025-10-03 | 3.12% |
| 2025-10-02 | 3.23% |
| 2025-10-01 | 3.27% |
| 2025-09-30 | 3.56% |
| 2025-09-29 | 3.64% |
| 2025-09-26 | 3.64% |
| 2025-09-25 | 3.55% |
| 2025-09-24 | 3.57% |
| 2025-09-23 | 3.53% |
| 2025-09-22 | 3.39% |
| 2025-09-19 | 3.45% |
| 2025-09-18 | 3.47% |
| 2025-09-17 | 3.41% |
| 2025-09-16 | 3.48% |
| 2025-09-15 | 3.44% |
| 2025-09-12 | 3.33% |
| 2025-09-11 | 3.28% |
| 2025-09-10 | 3.32% |
| 2025-09-09 | 3.31% |
| 2025-09-08 | 3.26% |
| 2025-09-05 | 3.23% |
| 2025-09-04 | 3.28% |
| 2025-09-03 | 3.28% |
| 2025-09-02 | 3.31% |
| 2025-08-29 | 3.30% |
| 2025-08-28 | 3.36% |
| 2025-08-27 | 3.31% |
| 2025-08-26 | 3.32% |
| 2025-08-25 | 3.26% |
| 2025-08-22 | 3.39% |
| 2025-08-21 | 3.31% |
| 2025-08-20 | 3.37% |
| 2025-08-19 | 3.34% |
| 2025-08-18 | 3.32% |
| 2025-08-15 | 3.42% |
| 2025-08-14 | 3.42% |
| 2025-08-13 | 3.45% |
| 2025-08-12 | 3.59% |
| 2025-08-11 | 3.64% |
| 2025-08-08 | 3.75% |
| 2025-08-07 | 3.61% |
| 2025-08-06 | 3.58% |
| 2025-08-05 | 3.54% |
| 2025-08-04 | 3.54% |
| 2025-08-01 | 3.61% |
| 2025-07-31 | 3.61% |
| 2025-07-30 | 3.42% |
| 2025-07-29 | 3.53% |
| 2025-07-28 | 3.46% |
| 2025-07-25 | 3.43% |
| 2025-07-24 | 3.40% |
| 2025-07-23 | 3.39% |
| 2025-07-22 | 3.52% |
| 2025-07-21 | 3.57% |
| 2025-07-18 | 3.63% |
| 2025-07-17 | 3.60% |
| 2025-07-16 | 3.51% |
| 2025-07-15 | 3.55% |
| 2025-07-14 | 3.49% |
| 2025-07-11 | 3.56% |
| 2025-07-10 | 3.47% |
| 2025-07-09 | 3.53% |
| 2025-07-08 | 3.56% |
| 2025-07-07 | 3.50% |
| 2025-07-03 | 3.55% |
| 2025-07-02 | 3.47% |
| 2025-07-01 | 3.57% |
| 2025-06-30 | 3.57% |
| 2025-06-27 | 3.61% |
| 2025-06-26 | 3.57% |
| 2025-06-25 | 3.41% |
| 2025-06-24 | 3.54% |
| 2025-06-23 | 3.51% |
| 2025-06-20 | 3.57% |
| 2025-06-18 | 3.47% |
| 2025-06-17 | 3.54% |
| 2025-06-16 | 3.36% |
| 2025-06-13 | 3.37% |
| 2025-06-12 | 3.32% |
| 2025-06-11 | 3.37% |
| 2025-06-10 | 3.40% |
| 2025-06-09 | 3.41% |
| 2025-06-06 | 3.46% |
| 2025-06-05 | 3.50% |
| 2025-06-04 | 3.43% |
| 2025-06-03 | 3.50% |
| 2025-06-02 | 3.50% |
| 2025-05-30 | 3.53% |
Showing the most recent 260 of 4,906 data points. The chart above shows the full history.
Related Metrics
About AstraZeneca PLC
AstraZeneca PLC operates as a global biopharmaceutical leader, dedicated to the entire process of bringing prescription medicines to market, from their initial discovery and development through manufacturing and commercialization. The company's extensive portfolio of treatments, including prominent examples like Tagrisso, Farxiga, and Symbicort, addresses critical areas such as cardiovascular, renal, metabolic, and oncological conditions. Furthermore, it provides essential solutions for COVID-19 and various rare diseases, with products like Vaxzevria and Soliris. AstraZeneca engages with primary and specialty care physicians worldwide, facilitating distribution through a robust network of representatives and local offices across the United Kingdom, continental Europe, the Americas, Asia, Africa, and Australasia. The firm actively drives innovation through strategic collaborations, partnering with entities such as Neurimmune AG for the development and commercialization of NI006, BenevolentAI for systemic lupus erythematosus drug discovery, Lunit for AI-powered digital pathology risk assessment in NSCLC, and Absci Corporation for AI-driven oncology target identification. Founded in 1992, the company was initially known as Zeneca Group PLC, subsequently rebranding to AstraZeneca PLC in April 1999, and maintains its headquarters in Cambridge, United Kingdom.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - General
- CEO
- Pascal Claude Roland Soriot